Diagnostic Imaging Devices - Central & Western Europe

  • Central & Western Europe
  • The Diagnostic Imaging Devices market market in Central & Western Europe is estimated to achieve a revenue of US$10.97bn by 2024.
  • It is anticipated that there will be a steady annual growth rate (CAGR 2024-2029) of 4.65%, leading to a market volume of US$13.77bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue, reaching US$11,930.00m in 2024.
  • In Central & Western Europe, Germany is leading the way in the adoption of advanced diagnostic imaging devices in the medical technology market.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Central & Western Europe is experiencing significant growth due to customer preferences for advanced medical technology, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Central & Western Europe are driving the demand for Diagnostic Imaging Devices. Patients and healthcare providers in this region prioritize accurate and efficient diagnosis, leading to a higher demand for advanced imaging equipment. Customers are increasingly seeking devices with enhanced imaging capabilities, such as high-resolution imaging and real-time imaging, to improve the accuracy of diagnoses and treatment planning. Additionally, there is a growing preference for portable and compact imaging devices that can be easily transported and used in different healthcare settings. Trends in the Diagnostic Imaging Devices market in Central & Western Europe are also contributing to its development. One prominent trend is the adoption of digital imaging technology, which offers several advantages over traditional film-based imaging. Digital imaging allows for faster image acquisition, storage, and sharing, leading to improved workflow efficiency and patient care. Another trend is the integration of artificial intelligence (AI) and machine learning algorithms into imaging devices, enabling automated image analysis and interpretation. This trend is expected to enhance diagnostic accuracy and efficiency, further driving market growth. Local special circumstances in Central & Western Europe are also influencing the development of the Diagnostic Imaging Devices market. The region has a well-established healthcare infrastructure and a high level of healthcare expenditure, which enables the adoption of advanced medical technologies. Additionally, there is a growing aging population in Central & Western Europe, leading to an increased demand for diagnostic imaging services. The prevalence of chronic diseases, such as cardiovascular diseases and cancer, also drives the need for accurate and timely diagnosis, further fueling the demand for imaging devices. Underlying macroeconomic factors are playing a crucial role in the development of the Diagnostic Imaging Devices market in Central & Western Europe. The region has a stable and growing economy, which supports investment in healthcare infrastructure and technology. Furthermore, favorable government policies and initiatives aimed at improving healthcare services and outcomes contribute to market growth. The presence of well-established medical device manufacturers and research institutions in the region also facilitates innovation and product development in the Diagnostic Imaging Devices market. In conclusion, the Diagnostic Imaging Devices market in Central & Western Europe is experiencing growth due to customer preferences for advanced technology, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for accurate and efficient diagnosis, along with the adoption of digital imaging technology and AI integration, are driving market development. The well-established healthcare infrastructure, aging population, and prevalence of chronic diseases in the region further contribute to market growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)